Yingxia Bao

Title: Yingxia Bao - Innovator in Pharmaceutical Compounds

Introduction

Yingxia Bao is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit specific biological pathways. His work is essential for advancing medical treatments and improving patient outcomes.

Latest Patents

Yingxia Bao holds a patent for a class of compounds known as 6,7-dimethoxy-3-(pyridin-2-yl)quinoline. This patent is focused on compounds that are effective in inhibiting RET, a receptor tyrosine kinase involved in various cancers. The patent details the formula (II) and includes isomers or pharmaceutically acceptable salts of these compounds. He has 1 patent to his name, showcasing his innovative approach to pharmaceutical research.

Career Highlights

Yingxia Bao is affiliated with Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., specifically working at the Baiyunshan Pharmaceutical General Factory. His role in this esteemed company allows him to contribute to the development of new and effective medications. His expertise in pharmaceutical compounds has positioned him as a valuable asset in the industry.

Collaborations

Yingxia Bao has collaborated with notable colleagues such as Shuhui Chen and Jikui Sun. These partnerships enhance the research and development process, leading to innovative solutions in the pharmaceutical sector.

Conclusion

Yingxia Bao's contributions to pharmaceutical innovations are noteworthy, particularly his work on compounds that inhibit RET. His patent and collaborations reflect his commitment to advancing medical science and improving therapeutic options.